On September 15, 2021 DURECT Corporation (Nasdaq: DRRX) reported that Dr. James E. Brown, President and CEO, Michael H. Arenberg, Chief Financial Officer, Dr. Norman Sussman, Chief Medical Officer, and Dr. WeiQi Lin, Executive Vice President of R&D, will be participating in a fireside chat hosted by Francois Brisebois, Managing Director, Senior Biotechnology Research Analyst at Oppenheimer & Co. Inc (Press release, DURECT, SEP 15, 2021, https://investors.durect.com/news-releases/news-release-details/durect-corporation-fireside-chat-oppenheimers-fall-healthcare [SID1234587754]).
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
Presentation details are as follows:
Oppenheimer’s Fall Healthcare Life Sciences & MedTech Summit
Date:
September 22, 2021
Time:
2:05 P.M. to 2:45 P.M. Eastern Standard Time
Format:
Fireside chat hosted by Francois Brisebois
Webcast:
The webcast link of the presentation will also be available by accessing DURECT’s homepage at www.durect.com and clicking on "Event Calendar" under the "Investors" section.
Management will also be available for virtual 1×1 meetings during the conference. If you would like to request a meeting, please contact Oppenheimer directly.